Dana Alhattab

Title: Dana Alhattab: Innovator in Immunoassay and 3D Bioprinting Technologies

Introduction

Dana Alhattab is a prominent inventor based in Thuwal, Saudi Arabia. He has made significant contributions to the fields of immunoassay and 3D bioprinting. With a total of 2 patents, his work focuses on developing innovative solutions for rapid disease detection and tissue modeling.

Latest Patents

One of Dana's latest patents involves the development of lateral flow immunochromatography (LFIA) peptide-based test strips. This technology is designed for the rapid detection of antigens and antibodies against specific pathogens, including COVID-19. The patent outlines a method for fabricating an LFIA that enhances the sensitivity, specificity, and accuracy of diagnostic tests through the use of fusion-epitopes peptides.

Another notable patent is for a coaxial nozzle used in 3D bioprinting. This invention facilitates the construction of 3D tissue models by incorporating multiple inlets for buffer solutions, peptides, and cells. The design allows for precise mixing and application of materials, which is crucial for creating viable tissue structures.

Career Highlights

Dana Alhattab is affiliated with the King Abdullah University of Science and Technology, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on healthcare and biotechnology.

Collaborations

Dana collaborates with esteemed colleagues, including Charlotte A E Hauser and Hattan Boshah. These partnerships enhance the scope and effectiveness of his research endeavors.

Conclusion

Dana Alhattab is a visionary inventor whose work in immunoassay and 3D bioprinting is paving the way for advancements in medical diagnostics and tissue engineering. His contributions are significant in addressing contemporary health challenges and improving biotechnological applications.